Evidence maps drive drug-makers to gold
Posted May 1st, 2013
If you showed Google Earth and Google Maps to your great-grandfather, his white-bearded jaw would drop. He’d marvel at the effortless zoom from a satellite view of planet earth to a roadmap of his hometown to a street view of his house.
Similar advances in data assembly are changing the way pharma companies look at information on products moving from the research pipeline into the commercial sphere.
The breakthrough is called an evidence map. At first glance, it resembles a standard information grid constructed in Microsoft Excel. But what it delivers is a unique, interlinked and concentric view of every domain a medication touches en route from design and synthesis to clinical testing and review, to the insurance formulary, the pharmacy shelf, and the patient’s home.